Medtronic plc Files 8-K on Financials
Ticker: MDT · Form: 8-K · Filed: Aug 20, 2024 · CIK: 1613103
| Field | Detail |
|---|---|
| Company | Medtronic PLC (MDT) |
| Form Type | 8-K |
| Filed Date | Aug 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: MDT
TL;DR
Medtronic dropped an 8-K on Aug 20th with financial updates. Check it out.
AI Summary
On August 20, 2024, Medtronic plc filed an 8-K to report on its results of operations and financial condition. The filing includes financial statements and exhibits, providing an update on the company's performance. Medtronic plc, formerly known as Medtronic Ltd, is based in Galway, Ireland.
Why It Matters
This filing provides investors with updated financial information and operational results for Medtronic plc, crucial for assessing the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any unusual risks or events.
Key Players & Entities
- Medtronic plc (company) — Filer of the 8-K
- 20240820 (date) — Filing date
- Medtronic Ltd (company) — Former name of Medtronic plc
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Medtronic plc's results of operations and financial condition, and to provide financial statements and exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on August 20, 2024.
What is Medtronic plc's standard industrial classification?
Medtronic plc's standard industrial classification is ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845].
What were some of Medtronic plc's former company names?
Medtronic plc was formerly known as Medtronic Ltd, Medtronic Holdings Ltd, and Kalani I Ltd.
Where is Medtronic plc's business address located?
Medtronic plc's business address is located at Building Two, Parkmore Business Park West, Galway, L2.
Filing Stats: 668 words · 3 min read · ~2 pages · Grade level 8.8 · Accepted 2024-08-20 06:46:44
Key Financial Figures
- $0.0001 — registered Ordinary shares, par value $0.0001 per share MDT New York Stock Exchange
Filing Documents
- mdt-20240820.htm (8-K) — 64KB
- exhibit991-fy25q1earningsr.htm (EX-99.1) — 556KB
- image_0a.jpg (GRAPHIC) — 25KB
- 0001613103-24-000140.txt ( ) — 979KB
- mdt-20240820.xsd (EX-101.SCH) — 7KB
- mdt-20240820_def.xml (EX-101.DEF) — 25KB
- mdt-20240820_lab.xml (EX-101.LAB) — 51KB
- mdt-20240820_pre.xml (EX-101.PRE) — 27KB
- mdt-20240820_htm.xml (XML) — 18KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition On August 20, 2024, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its first quarter fiscal year 2025 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
01. Exhibits
Item 9.01. Exhibits. (d) List of Exhibits Exhibit Number Description 99.1 Press release of Medtronic plc, dated August 20, 2024 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Medtronic plc By /s/ Gary Corona Date: August 20, 2024 Gary Corona Senior Vice President and Interim Chief Financial Officer (Principal Financial Officer) EXHIBIT INDEX Exhibit Number Description 99.1 Press release of Medtronic plc, dated August 20, 2024 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).